Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Interest & Investment Income (2017 - 2025)

Avricore Health has reported Interest & Investment Income over the past 6 years, most recently at $2939.3 for Q4 2025.

  • Quarterly Interest & Investment Income rose 297.49% to $2939.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8727.7 through Dec 2025, up 883.65% year-over-year, with the annual reading at $8677.4 for FY2025, 861.97% up from the prior year.
  • Interest & Investment Income was $2939.3 for Q4 2025 at Avricore Health, up from $2432.8 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $2939.3 in Q4 2025 and troughed at $6.6 in Q3 2024.
  • The 5-year median for Interest & Investment Income is $608.54 (2025), against an average of $1037.9.
  • Year-over-year, Interest & Investment Income plummeted 99.72% in 2023 and then surged 36774.29% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $386.35 in 2021, then surged by 336.09% to $1684.8 in 2022, then crashed by 60.94% to $658.14 in 2023, then rose by 12.36% to $739.47 in 2024, then surged by 297.49% to $2939.3 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Interest & Investment Income are $2939.3 (Q4 2025), $2432.8 (Q3 2025), and $2796.6 (Q2 2025).